CN111217896A - Application of ginseng PgWRKY4X transcription factor in regulating and controlling ginsenoside compound content in ginseng - Google Patents

Application of ginseng PgWRKY4X transcription factor in regulating and controlling ginsenoside compound content in ginseng Download PDF

Info

Publication number
CN111217896A
CN111217896A CN202010129213.XA CN202010129213A CN111217896A CN 111217896 A CN111217896 A CN 111217896A CN 202010129213 A CN202010129213 A CN 202010129213A CN 111217896 A CN111217896 A CN 111217896A
Authority
CN
China
Prior art keywords
ginseng
pgwrky4x
ginsenoside
transcription factor
regulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010129213.XA
Other languages
Chinese (zh)
Other versions
CN111217896B (en
Inventor
高文远
王娟
姚陆
贺军平
刘静静
许馨丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University
Original Assignee
Tianjin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University filed Critical Tianjin University
Priority to CN202010129213.XA priority Critical patent/CN111217896B/en
Publication of CN111217896A publication Critical patent/CN111217896A/en
Application granted granted Critical
Publication of CN111217896B publication Critical patent/CN111217896B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Nutrition Science (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses application of a ginseng PgWRKY4X transcription factor in regulating and controlling the content of ginsenoside compounds in ginseng; the amino acid sequence of the ginseng PgWRKY4X transcription factor is shown in SEQ ID No. 1. Experiments prove that the transcription factor PgWRKY4X of the ginseng can be combined with the promoter of the PgSE gene of the ginseng, so that the expression of key enzyme PgSE on a ginsenoside synthesis path is improved, and the content of ginsenoside compounds in the ginseng is further improved. The ginseng PgWRKY4X transcription factor, the coding gene thereof and the overexpression recombinant vector containing the coding gene can be used for regulating and improving the content of ginsenoside compounds in ginseng.

Description

Application of ginseng PgWRKY4X transcription factor in regulating and controlling ginsenoside compound content in ginseng
Technical Field
The invention belongs to the field of biochemistry, relates to a plant gene regulation secondary metabolite, and particularly relates to an application of a ginseng PgWRKY4X transcription factor and a coding gene in regulating and controlling the content of ginsenoside compounds in ginseng.
Background
Ginseng (panaxginngcc.a.mey) belongs to a perennial herbaceous plant of the family araliaceae, and in china, ginseng has historically been regarded as the king of centella asiatica. As a traditional precious Chinese medicinal material, ginseng has rich pharmacological actions including antidiabetic activity, anti-stress activity, antioxidant capacity, immune system regulating action, anticancer activity and the like. Wherein, the triterpenoid ginsenoside plays an important role. Ginsenosides in ginseng are classified into three groups according to the difference in structure: one type is protopanaxadiol type saponin, including ginsenoside Rb1,Rb2,Rc,Rd,Rg3,Rh2(ii) a One type is protopanaxatriol saponin, including ginsenoside Re, Rf, and ginsenoside Rg1,Rg2,Rh1(ii) a Yet another class is oleanolic type saponins, including ginsenoside Ro. The pharmacopeia contains ginsenoside Rb1,Rg1The Re content is used as the index of ginsenoside substances to judge the quality of the ginseng medicinal material.
The synthesis of ginsenoside in ginseng is regulated by transcription factors, and the analysis of the regulation mechanism has some problems, so that the research on the regulation mechanism of ginsenoside compound accumulation in ginseng has important significance for production and academic research, but no report on the application of the transcription factor PgWRKY4X and coding gene in regulating the content of ginsenoside compound in ginseng exists at present.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides the application of the transcription factor PgWRKY4X of ginseng in regulating and controlling the content of ginsenoside compounds in ginseng.
The second purpose of the invention is to provide the application of the coding gene of the transcription factor PgWRKY4X of ginseng in regulating and controlling the content of ginsenoside compounds in ginseng.
The third purpose of the invention is to provide the application of the over-expression recombinant vector containing the coding gene of the transcription factor PgWRKY4X of ginseng in regulating and controlling the content of ginsenoside compounds in ginseng.
The technical scheme of the invention is summarized as follows:
application of transcription factor PgWRKY4X in regulating ginsenoside compound content in Ginseng radix; the amino acid sequence of the ginseng PgWRKY4X transcription factor is shown in SEQ ID No. 1.
The ginsenoside compound is ginsenoside Rb1Or Rg1Or Re.
The application of the coding gene of the ginseng PgWRKY4X transcription factor in regulating and controlling the content of ginsenoside compounds in the ginseng is disclosed, wherein the nucleotide sequence of the coding gene is shown as SEQ ID No. 2.
The ginsenoside compound is ginsenoside Rb1Or Rg1Or Re.
An application of an overexpression recombinant vector containing a ginseng PgWRKY4X transcription factor coding gene in regulating and controlling the content of ginsenoside compounds in ginseng is disclosed, wherein a nucleotide sequence of the overexpression recombinant vector is shown as SEQ ID No. 3.
The ginsenoside compound is ginsenoside Rb1Or Rg1Or Re.
Has the advantages that:
experiments prove that the transcription factor PgWRKY4X of the ginseng can be combined with the promoter of the PgSE gene of the ginseng, so that the expression of key enzyme PgSE on a ginsenoside synthesis path is improved, and the content of ginsenoside compounds in the ginseng is further improved. The ginseng PgWRKY4X transcription factor, the coding gene thereof and the overexpression recombinant vector containing the coding gene can be used for regulating and improving the content of ginsenoside compounds in ginseng.
Drawings
FIG. 1 is an overexpression recombinant vector containing the coding gene of the transcription factor PgWRKY4X of ginseng;
FIG. 2 is a pCAMBIA1300-PgWRKY4X-RNAi interference recombinant vector;
FIG. 3 is a fluorescent detection map of PgWRKY4X overexpression suspension cells (PgWRKY4X-OE) and PgWRKY4X-RNAi interference suspension cells (PgWRKY4X-R), wherein DAPI is a nuclear localization micrograph, GFP fluorescence, Brightfield and Merge are respectively fluorescence, optical lens and combined micrographs;
FIG. 4 shows the transcription levels of PgWRKY4X overexpression suspension cells (PgWRKY4X-OE), PgWRKY4X-RNAi interference suspension cells (PgWRKY4X-R) and PgWRKY4X (a) and PgSE (b) genes in control group;
FIG. 5 is a graph showing the expression levels of PgWRKY4X overexpression suspension cells (PgWRKY4X-OE), PgWRKY4X-RNAi interference suspension cells (PgWRKY4X-R) and PgSE proteins in a control group;
FIG. 6 shows PgWRKY4X overexpression suspension cells (PgWRKY4X-OE), PgWRKY4X-RNAi interference suspension cells (PgWRKY4X-R) and ginsenoside Rb in control group1(a),Rg1(b) The content of Re (c);
FIG. 7 is a verification diagram of binding site of transcription factor PgWRKY4X, in which probe is a biotin labeled probe, GST-PgWRKY4X is a protein expressed by PgWRKY4X, and completter is a Competitor.
Detailed Description
The invention is further described with reference to the following figures and examples, which do not limit the scope of the invention.
First, experimental material and instrument
Plant total RNA extraction kit (B511311, Shanghai Biotechnology, Ltd., China), first-strand cDNA Synthesis kit (B639252, Shanghai Biotechnology, Ltd., China), ginsenoside Rb1,Rg1Re standard (Dalian Meiren Biotechnology Co., Ltd.). Fluorescence microscopy (LEICADM5000B, Buffalo Grove, IL, France).
Second, Experimental methods
1. Construction of recombinant vector containing ginseng PgWRKY4X transcription factor coding gene
Construction of an overexpression recombinant vector containing a ginseng PgWRKY4X transcription factor coding gene:
through PCR technology, specific primers PgWRKY4X-F-R (SEQ ID No.4 and SEQ ID No.5 in Table 1) are used, cDNA obtained by reverse transcription of total RNA extracted from adventitious roots of ginseng is used as a template, a PgWRKY4X encoding gene (shown as SEQ ID No.2, and a corresponding amino acid sequence is SEQ ID No.1) is amplified and inserted into a pCAMBIA1300 vector (Beijing Huayue), and a pCAMBIA1300-PgWRKY4X recombinant vector, namely an overexpression recombinant vector (shown as SEQ ID No. 3) containing the ginseng PgWRKY4X transcription factor encoding gene is constructed (shown as FIG. 1).
Construction of pCAMBIA1300-PgWRKY4X-RNAi interference recombinant vector:
firstly, a gene sequence of a PgWRKY4X forward fragment is amplified by using a PCR technology and a specific primer PgWRKY4X-P (SEQ ID No.6 and SEQ ID No.7 in Table 1) as a template and an encoding gene sequence of PgWRKY4X as a template, and is inserted into a pCAMBIA1300 vector to obtain a pCAMBIA1300-PgWRKY4X-P recombinant vector, then a gene sequence of a PgWRKY4X-N (SEQ ID No.8 and SEQ ID No.9 in Table 1) as a specific primer is amplified by using a PCR technology and an encoding gene sequence of PgWRKY4X as a template to obtain a gene sequence of a PgWRKY4 5631 reverse fragment, and finally the reverse fragment is constructed on the pCAMBIA1300-PgWRKY4X-P recombinant vector containing the forward fragment to obtain the pCAMBIA1300-PgWRKY 4-X-N recombinant vector (pCAMBIA 1300-X-PgWRKY 4-2-P recombinant vector).
TABLE 1 primer List
Figure BDA0002395316460000031
2. Genetic transformation mediated by agrobacterium tumefaciens GV3101
2.1 transformation and activation of Agrobacterium strains
Respectively transferring an overexpression recombinant vector containing a ginseng PgWRKY4X transcription factor coding gene and a pCAMBIA1300-PgWRKY4X-RNAi interference recombinant vector into GV3101 agrobacterium (Beijing Huayu biology), and culturing on YEB culture medium (1g/L yeast extract, 5g/L peptone, 5g/L beef extract, 5g/L sucrose, 0.5g/L magnesium sulfate, pH7.0) added with 50mg/L kanamycin and 50mg/L rifampicin to respectively obtain the transformation agrobacterium of the overexpression recombinant vector containing the ginseng PgWRKY4X transcription factor coding gene and the transformation agrobacterium containing the pCAMBIA1300-PgWRKY4X-RNAi interference recombinant vector. Single colonies of the transformed Agrobacterium containing the recombinant vectors were picked up and inoculated into 1mL of YEB medium containing the corresponding antibiotic, and cultured overnight at 28 ℃ with shaking at 200 rpm. Adding 200 μ L of the above bacterial liquid into 10mL YEB culture medium containing corresponding antibiotic, shaking at 200rpm and 28 deg.CCulturing overnight to make the concentration of bacterial liquid OD600The value was 0.6. Centrifuging at room temperature at 4000rpm for 10min, discarding supernatant, and diluting with 1/2MS (adding acetosyringone AS, final concentration 100 μ M) liquid culture medium to OD600And continuing suspension culture for 2h with the value of 0.4 to obtain the agrobacterium culture solution.
2.2 Pre-culture of suspension cells of Ginseng radix
Inoculating the new subculture ginseng suspension cells to a pre-culture solid medium 1/2MS (added with 100 mu M acetosyringone AS), and performing dark culture at 25 ℃ for 2 d.
2.3 Co-culture of Agrobacterium and Ginseng suspension cells
Before infection, the pre-cultured ginseng suspension cells are taken out and placed into the culture solution obtained in the step 2.1 for dip dyeing for 10min, and the ginseng suspension cells are gently shaken to be in full contact with the bacterial solution. Taking out infected ginseng suspension cells, sucking residual bacteria on the surface of the ginseng suspension cells by using sterile absorbent paper, transferring the ginseng suspension cells to a co-culture medium (solid) 1/2MS (adding 100 mu M acetosyringone AS), and co-culturing for 2d in the dark.
2.4 screening of transformed Ginseng suspension cells
And (3) transferring the cells obtained in the step (2.3) into a sterile culture medium 1/2MS + Cef mycin Cef250mg/L (solid), carrying out dark culture at 25 ℃ for 3 days, washing the ginseng suspension cells with sterile water, carrying out suction drying with sterile absorbent paper, transferring into the sterile culture medium, continuing the culture, and repeating for 3 times until no obvious thalli grow out. Then selecting the ginseng suspension cells with good growth state, transferring the ginseng suspension cells to a 1/2MS culture medium without antibiotics for continuous recovery culture for 20 days, and then performing normal subculture on a solid culture medium and a liquid culture medium respectively to obtain transformed ginseng suspension cells: PgWRKY4X overexpression suspension cells (PgWRKY4X-OE) and PgWRKY4X-RNAi interference suspension cells (PgWRKY 4X-R).
2.5 identification of Positive transformed Ginseng suspension cells
2.5.1qRT-PCR method for identifying positively transformed ginseng suspension cells
Extracting total RNA in ginseng suspension cells by using a method of a plant total RNA extraction kit, performing reverse transcription to generate cDNA (refer to the kit use instruction), and analyzing the transcription level of PgWRKY4X (SEQ ID No.12 and SEQ ID No.13 in Table 2) by using a qRT-PCR (Table 2) method to identify, wherein the PCR operation conditions are as follows: at 95 ℃ for 10 min; the actin (DQ243702.1) gene was used as an internal reference gene (SEQ ID No.10 and SEQ ID No.11 in Table 2) after cycling 40 times at 95 ℃, 10 seconds, 60 ℃, 30 seconds.
TABLE 2 primer List
Figure BDA0002395316460000041
2.5.2 Green fluorescence identification of Positive transformed Ginseng suspension cells
Under a fluorescence microscope, the successfully transformed ginseng suspension cells PgWRKY4X emit green fluorescence, which indicates that the group of cells are positive transformed ginseng suspension cells.
qRT-PCR analysis of PgSE Gene expression
The enzyme expressed by PgSE is a key enzyme in the synthesis pathway of ginsenoside substances in ginseng, so that the transcription level of PgSE is measured to confirm whether the PgWRKY4X transcription factor has a regulating effect on the synthesis of ginsenoside substances. The procedure is as in step 2.5.1, primers for PgSE are shown in Table 2 as SEQ ID No.14 and SEQ ID No. 15.
SDS-PAGE analysis of PgSE protein expression
The enzyme expressed by the PgSE is a key enzyme in the synthesis pathway of ginsenoside substances in ginseng, so that the protein expression level of the PgSE is determined by SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis), and whether the synthesis of the ginsenoside substances is regulated after the overexpression or interference of the PgWRKY4X transcription factor can be proved.
5. Through the method of EMSA, the binding site of the transcription factor PgWRKY4X is explored
And (3) according to the PgWRKY4X transcription factor family, predicting the binding site of the PgSE promoter of the target gene, designing a corresponding double-stranded oligonucleotide probe, and carrying out biotin labeling on the oligonucleotide probe to obtain a biotin labeled probe. According to the use instruction of a chemiluminescence method EMSA kit (Shanghai Biyuntian biotechnology, Co., Ltd.), whether the PgWRKY4X transcription factor can activate the promoter of the key gene PgSE is verified through an EMSA experiment.
6. Determination of ginsenoside substance content in positive transformed ginseng suspension cells
Precisely weighing 0.2g of dry and crushed ginseng suspension cells, placing the dry and crushed ginseng suspension cells in a 100mL triangular flask with a plug, adding 40mL of methanol, carrying out water bath at 60 ℃ for 2h, carrying out suction filtration while the solution is hot, collecting filtrate, adding 20mL of methanol into the triangular flask, and carrying out water bath on filter paper and filter residues again at 60 ℃ for 2 h. After the filtrate was evaporated to dryness, the filtrate was dissolved in 10mL of distilled water, extracted with 20mL of n-butanol, and the n-butanol layer was collected and evaporated by rotation (temperature 70 ℃ C., rotation speed 50rpm) to a constant volume of 1 mL. Filtering with 0.22 μm microporous membrane to obtain sample. The liquid phase system used was Shimadzu LC-2030C development system (Shimadzu, Kyoto, Japan). Chromatographic conditions are as follows: column Kromasil C18(4.6 mm. times.250 mm,5 μm); mobile phase: a-acetonitrile, B-water; flow rate: 1.0 mL/min; detection wavelength: 203nm, column temperature: 35 ℃; sample introduction amount: 20 μ L. Gradient: A-ACN: 35min, 20%; 40min, 30%; 50min, 31%; 60min, 32%; 45% for 70 min; 100min, 60%; 110min, 60%; 111min, 20%; 120min, 20 percent.
Third, experimental results
1. Identification of positively transformed Ginseng suspension cells
1.1 identification of PgWRKY4X overexpressing suspension cells
Identification of PgWRKY4X overexpressing suspension cells (PgWRKY4X-OE) there are three methods. The first method is to observe whether the PgWRKY4X overexpression suspension cells emit green fluorescence or not under a fluorescence microscope, and the PgWRKY4X overexpression suspension cells can be seen from FIG. 3 to emit green fluorescence under the fluorescence microscope. The second method is to detect the transcription level of PgWRKY4X in the over-expression transformed ginseng suspension cells, and the relative expression quantity of the PgWRKY4X gene in the over-expression group is 4-5 times that of the control group as shown in figure 4 (a). The third method is to measure the protein level of PgWRKY4X, and as shown in FIG. 5, the expression level of PgWRKY4X protein in the overexpression group is obviously higher than that in the control group. The result shows that the PgWRKY4X overexpression suspension cell is the PgWRKY4X overexpression positive transformation ginseng suspension cell.
1.2 PgWRKY4X-RNAi interference suspension cell identification
PgWRKY4X-RNAi interference suspension cell (PgWRKY4X-R) identification has the following two methods. The first method is to measure the transcription level of PgWRKY4X gene interfering suspension cells, and the relative expression level of the PgWRKY4X gene in the interfering group is 2-3 times lower than that in the control group as shown in figure 4 (b). The second method is to observe whether the interfering suspension cells emit green fluorescence under a fluorescence microscope, and as shown in fig. 3, the interfering suspension cells emit green fluorescence under the fluorescence microscope. Therefore, the PgWRKY4X-RNAi interference suspension cell is the PgWRKY4X-RNAi interference positive transformation ginseng suspension cell.
2. Determination of ginsenoside substance content
Determination of ginsenoside Rb as representative substance in ginsenoside substances1,Rg1Re content (FIG. 6), ginsenoside Rb found in positively overexpressed suspension cells1The content of ginsenoside Rb is about 6.8 times of that of the control group and the content of ginsenoside Rb in the interference group is about 6.8 times of that of ginsenoside Rb in the control group1Is about 2.1 times lower than the control group (fig. 6 a); ginsenoside Rg1The content of the ginsenoside is about 3.2 times of that of the control group, and the ginsenoside Rg of the interference group1Is about 2.6 times lower than the control group (fig. 6 b); the content of ginsenoside Re was about 3.1 times that of the control group, and the content of ginsenoside Re in the interfering group was about 1.8 times lower than that of the control group (fig. 6 c). The obtained PgWRKY4X transcription factor can increase ginsenoside content in Ginseng radix.
Regulating expression of relevant enzymes for synthesizing ginsenoside substances by PgWRKY4X transcription factor
In order to investigate whether the PgWRKY4X transcription factor has a regulating effect on the synthesis of ginsenosides in ginseng, a key enzyme PgSE on the synthesis pathway of ginsenosides was studied. First, we measured the expression of PgSE protein, and as shown in fig. 5, the expression of PgSE protein in over-expressed suspension cells was significantly increased and the expression of PgSE protein in RNAi-interfered group was significantly decreased, compared to the control group. We detected the transcription level of PgSE gene (FIG. 4b), consistent with the protein expression results, over-expressed suspension cells have obviously increased PgSE gene transcription, and RNAi interference groups have obviously decreased PgSE gene transcription. It is speculated that the PgWRKY4X transcription factor may bind to the PgSE gene promoter to regulate PgSE expression. To confirm this hypothesis, we performed EMSA verification (fig. 7), which revealed that the PgWRKY4X transcription factor did bind to the promoter of the PgSE gene and regulate the synthesis of ginsenosides by regulating the expression of the PgSE gene.
Experiments prove that the ginseng transcription factor PgWRKY4X influences the synthesis and yield of ginsenoside substances by regulating and controlling the gene expression and protein expression of the ginseng squalene epoxidase (PgSE).
The above-described embodiments are intended to be illustrative of the nature of the invention, but those skilled in the art will recognize that the scope of the invention is not limited to the specific embodiments.
Sequence listing
<110> Tianjin university
Application of ginseng PgWRKY4X transcription factor in regulating and controlling ginsenoside compound content in ginseng
<160>15
<170>SIPOSequenceListing 1.0
<210>1
<211>344
<212>PRT
<213> Ginseng radix (Panax ginseng)
<400>1
Met Asp Tyr Thr Thr Phe Val Asp Thr Ser Leu Asp Leu Asn Thr Asn
1 5 10 15
Pro Leu Gln Leu Phe Thr Glu Thr Pro Lys Gln Glu Met Gln Ser Asn
20 25 30
Phe Ile Asp Phe Gly Met Lys Thr Val Ser Val Lys Gln Glu Ile Ser
35 40 45
Ser Gly Ala Leu Thr Glu Glu Leu Lys Arg Val Ser Ala Glu Asn Lys
50 55 60
Lys Leu Thr Glu Met Leu Thr Val Val Cys Glu Asn Tyr Asn Ala Leu
65 70 75 80
Arg Ser Asn Leu Met Glu Tyr Ile Asp Lys Asn Pro Gln Pro Thr Thr
85 90 95
Thr Asp Thr Ala Ser Thr Arg Lys Arg Lys Ile Ser Thr Thr Thr Ser
100 105 110
Cys Met Ile Asn Asn Lys Val Asn Ser Asp Gln Ala Ala AlaAla Ala
115 120 125
Ala Ala Ala Gly Phe Gly Asn Asn Ser Glu Ser Cys Ser Ser Asp Glu
130 135 140
Asp Asn Asn Ser Phe Lys Lys Phe Lys Pro Arg Glu Glu Glu Met Ile
145 150 155 160
Lys Asp Lys Ile Ser Arg Val Tyr Val Arg Ser Glu Ala Ser Asp Thr
165 170 175
Thr Ser Leu Val Val Lys Asp Gly Tyr Gln Trp Arg Lys Tyr Gly Gln
180 185 190
Lys Val Thr Arg Asp Asn Pro Ser Pro Arg Ala Tyr Phe Lys Cys Ser
195 200 205
Phe Ala Pro Thr Cys Pro Val Lys Lys Lys Val Gln Arg Ser Ile Glu
210 215 220
Asp Gln Ser Ile Leu Val Ala Thr Tyr Glu Gly Glu His Asn His Pro
225 230 235 240
His Pro Ser Lys Val Glu Ala Asn Ser Ser Ser Asn Arg Cys Ala Ala
245 250 255
Pro Cys Ser Thr Ser Leu Gly Ser Ser Gly Pro Thr Ile Thr Leu Asp
260 265 270
Leu Thr Lys Ser Lys Ser Asn Gln Asp Ala Asn Lys Ser Phe Val Arg
275 280 285
Arg Ile Glu Ser Pro Glu Phe Gln Gln Phe Leu Val Asp Gln Met Ala
290 295 300
Ser Ser Leu Thr Lys Asp Pro Ser Phe Lys Ala Ala Leu Ala Ala Ala
305 310 315 320
Ile Ser Gly Lys Ile Leu Gln His Asn Gln Thr Asp Gly Glu Met Val
325 330 335
Lys Phe Lys Gly Leu Glu Arg Val
340
<210>2
<211>1032
<212>DNA
<213> Ginseng radix (Panax ginseng)
<400>2
atggattaca ctaccttcgt tgatacctcc ttggatttga acactaatcc attgcagttg 60
ttcactgaaa ccccaaagca agaaatgcag tccaacttta ttgacttcgg tatgaagacc 120
gtttccgtta agcaagagat ttcttctggt gctttgaccg aagaattgaa gagagtttct 180
gccgagaaca aaaagttgac tgaaatgttg accgttgtct gcgaaaatta caacgctttg 240
agatctaact tgatggagta catcgataag aacccacaac ctactactac tgatactgct 300
tctactagaa agaggaagat ttctactacc acctcctgca tgattaacaa caaggttaat 360
tctgatcaag ctgctgctgc agctgctgcc gctggttttg gtaacaattc tgaatcttgt 420
tcttccgacg aggacaacaa ttctttcaag aagtttaagc caagggaaga agagatgatc 480
aaggacaaaa tctccagagt ttacgttaga tctgaagctt ctgataccac ttccttggtt 540
gttaaggatg gttatcaatg gcgtaagtac ggtcaaaagg ttactagaga taatccatct 600
ccaagagctt acttcaagtg ttcttttgct ccaacttgtc cagttaagaa gaaggtccaa 660
agatccatcg aagatcaatc cattttggtt gctacttacg aaggtgaaca taatcatcca 720
catccatcta aggttgaagc caactcttca tctaatagat gtgctgctcc atgttctaca 780
tctttgggtt cttcaggtcc aactatcact ttggacttga ctaagtccaa gtctaatcaa 840
gatgccaaca agtccttcgt cagaagaata gaatcaccag aattccaaca gttcttggtt 900
gatcaaatgg cttcttcatt gaccaaggat ccatctttta aagctgcttt ggctgctgct 960
atttctggta aaatcttgca acacaatcaa accgatggtg agatggttaa gttcaaaggt 1020
ttggaaagag tt 1032
<210>3
<211>11535
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>3
aattcccatg gagtcaaaga ttcaaataga ggacctaaca gaactcgccg taaagactgg 60
cgaacagttc atacagagtc tcttacgact caatgacaag aagaaaatct tcgtcaacat 120
ggtggagcac gacacgcttg tctactccaa aaatatcaaa gatacagtct cagaagacca 180
aagggcaatt gagacttttc aacaaagggt aatatccgga aacctcctcg gattccattg 240
cccagctatc tgtcacttta ttgtgaagat agtggaaaag gaaggtggct cctacaaatg 300
ccatcattgc gataaaggaa aggccatcgt tgaagatgcc tctgccgaca gtggtcccaa360
agatggaccc ccacccacga ggagcatcgt ggaaaaagaa gacgttccaa ccacgtcttc 420
aaagcaagtg gattgatgtg atatctccac tgacgtaagg gatgacgcac aatcccacta 480
tccttcgcaa gacccttcct ctatataagg aagttcattt catttggaga ggacagggta 540
cccggggatc catggattac actaccttcg ttgatacctc cttggatttg aacactaatc 600
cattgcagtt gttcactgaa accccaaagc aagaaatgca gtccaacttt attgacttcg 660
gtatgaagac cgtttccgtt aagcaagaga tttcttctgg tgctttgacc gaagaattga 720
agagagtttc tgccgagaac aaaaagttga ctgaaatgtt gaccgttgtc tgcgaaaatt 780
acaacgcttt gagatctaac ttgatggagt acatcgataa gaacccacaa cctactacta 840
ctgatactgc ttctactaga aagaggaaga tttctactac cacctcctgc atgattaaca 900
acaaggttaa ttctgatcaa gctgctgctg cagctgctgc cgctggtttt ggtaacaatt 960
ctgaatcttg ttcttccgac gaggacaaca attctttcaa gaagtttaag ccaagggaag 1020
aagagatgat caaggacaaa atctccagag tttacgttag atctgaagct tctgatacca 1080
cttccttggt tgttaaggat ggttatcaat ggcgtaagta cggtcaaaag gttactagag 1140
ataatccatc tccaagagct tacttcaagt gttcttttgc tccaacttgt ccagttaaga 1200
agaaggtcca aagatccatc gaagatcaat ccattttggt tgctacttac gaaggtgaac 1260
ataatcatcc acatccatct aaggttgaag ccaactcttc atctaataga tgtgctgctc 1320
catgttctac atctttgggt tcttcaggtc caactatcac tttggacttg actaagtcca 1380
agtctaatca agatgccaac aagtccttcg tcagaagaat agaatcacca gaattccaac 1440
agttcttggt tgatcaaatg gcttcttcat tgaccaagga tccatctttt aaagctgctt 1500
tggctgctgc tatttctggt aaaatcttgc aacacaatca aaccgatggt gagatggtta 1560
agttcaaagg tttggaaaga gtttctagag tcgacactag taccatggtg agcaagggcg 1620
aggagctgtt caccggggtg gtgcccatcc tggtcgagct ggacggcgac gtaaacggcc 1680
acaagttcag cgtgtccggc gagggcgagg gcgatgccac ctacggcaag ctgaccctga 1740
agttcatctg caccaccggc aagctgcccg tgccctggcc caccctcgtg accaccctga 1800
cctacggcgt gcagtgcttc agccgctacc ccgaccacat gaagcagcac gacttcttca 1860
agtccgccat gcccgaaggc tacgtccagg agcgcaccat cttcttcaag gacgacggca 1920
actacaagac ccgcgccgag gtgaagttcg agggcgacac cctggtgaac cgcatcgagc 1980
tgaagggcat cgacttcaag gaggacggca acatcctggg gcacaagctg gagtacaact 2040
acaacagcca caacgtctat atcatggccg acaagcagaa gaacggcatc aaggtgaact 2100
tcaagatccg ccacaacatc gaggacggca gcgtgcagct cgccgaccac taccagcaga 2160
acacccccat cggcgacggc cccgtgctgc tgcccgacaa ccactacctg agcacccagt 2220
ccgccctgag caaagacccc aacgagaagc gcgatcacat ggtcctgctg gagttcgtga 2280
ccgccgccgg gatcactctc ggcatggacg agctgtacaa gtaactgcag gttcgagtat 2340
tatggcattg ggaaaactgt ttttcttgta ccatttgttg tgcttgtaat ttactgtgtt 2400
ttttattcgg ttttcgctat cgaactgtga aatggaaatg gatggagaag agttaatgaa 2460
tgatatggtc cttttgttca ttctcaaatt aatattattt gttttttctc ttatttgttg 2520
tgtgttgaat ttgaaattat aagagatatg caaacatttt gttttgagta aaaatgtgtc 2580
aaatcgtggc ctctaatgac cgaagttaat atgaggagta aaacactaag cttggcactg 2640
gccgtcgttt tacaacgtcg tgactgggaa aaccctggcg ttacccaact taatcgcctt 2700
gcagcacatc cccctttcgc cagctggcgt aatagcgaag aggcccgcac cgatcgccct 2760
tcccaacagt tgcgcagcct gaatggcgaa tgctagagca gcttgagctt ggatcagatt 2820
gtcgtttccc gccttcagtt taaactatca gtgtttgaca ggatatattg gcgggtaaac 2880
ctaagagaaa agagcgttta ttagaataac ggatatttaa aagggcgtga aaaggtttat 2940
ccgttcgtcc atttgtatgt gcatgccaac cacagggttc ccctcgggat caaagtactt 3000
tgatccaacc cctccgctgc tatagtgcag tcggcttctg acgttcagtg cagccgtctt 3060
ctgaaaacga catgtcgcac aagtcctaag ttacgcgaca ggctgccgcc ctgccctttt 3120
cctggcgttt tcttgtcgcg tgttttagtc gcataaagta gaatacttgc gactagaacc 3180
ggagacatta cgccatgaac aagagcgccg ccgctggcct gctgggctat gcccgcgtca 3240
gcaccgacga ccaggacttg accaaccaac gggccgaact gcacgcggcc ggctgcacca 3300
agctgttttc cgagaagatc accggcacca ggcgcgaccg cccggagctg gccaggatgc 3360
ttgaccacct acgccctggc gacgttgtga cagtgaccag gctagaccgc ctggcccgca 3420
gcacccgcga cctactggac attgccgagc gcatccagga ggccggcgcg ggcctgcgta 3480
gcctggcaga gccgtgggcc gacaccacca cgccggccgg ccgcatggtg ttgaccgtgt 3540
tcgccggcat tgccgagttc gagcgttccc taatcatcga ccgcacccgg agcgggcgcg 3600
aggccgccaa ggcccgaggc gtgaagtttg gcccccgccc taccctcacc ccggcacaga 3660
tcgcgcacgc ccgcgagctg atcgaccagg aaggccgcac cgtgaaagag gcggctgcac 3720
tgcttggcgt gcatcgctcg accctgtacc gcgcacttga gcgcagcgag gaagtgacgc 3780
ccaccgaggc caggcggcgc ggtgccttcc gtgaggacgc attgaccgag gccgacgccc 3840
tggcggccgc cgagaatgaa cgccaagagg aacaagcatg aaaccgcacc aggacggcca 3900
ggacgaaccg tttttcatta ccgaagagat cgaggcggag atgatcgcgg ccgggtacgt 3960
gttcgagccg cccgcgcacg tctcaaccgt gcggctgcat gaaatcctgg ccggtttgtc 4020
tgatgccaag ctggcggcct ggccggccag cttggccgct gaagaaaccg agcgccgccg 4080
tctaaaaagg tgatgtgtat ttgagtaaaa cagcttgcgt catgcggtcg ctgcgtatat 4140
gatgcgatga gtaaataaac aaatacgcaa ggggaacgca tgaaggttat cgctgtactt 4200
aaccagaaag gcgggtcagg caagacgacc atcgcaaccc atctagcccg cgccctgcaa 4260
ctcgccgggg ccgatgttct gttagtcgat tccgatcccc agggcagtgc ccgcgattgg 4320
gcggccgtgc gggaagatca accgctaacc gttgtcggca tcgaccgccc gacgattgac 4380
cgcgacgtga aggccatcgg ccggcgcgac ttcgtagtga tcgacggagc gccccaggcg 4440
gcggacttgg ctgtgtccgc gatcaaggca gccgacttcg tgctgattcc ggtgcagcca 4500
agcccttacg acatatgggc caccgccgac ctggtggagc tggttaagca gcgcattgag 4560
gtcacggatg gaaggctaca agcggccttt gtcgtgtcgc gggcgatcaa aggcacgcgc 4620
atcggcggtg aggttgccga ggcgctggcc gggtacgagc tgcccattct tgagtcccgt 4680
atcacgcagc gcgtgagcta cccaggcact gccgccgccg gcacaaccgt tcttgaatca 4740
gaacccgagg gcgacgctgc ccgcgaggtc caggcgctgg ccgctgaaat taaatcaaaa 4800
ctcatttgag ttaatgaggt aaagagaaaa tgagcaaaag cacaaacacg ctaagtgccg 4860
gccgtccgag cgcacgcagc agcaaggctg caacgttggc cagcctggca gacacgccag 4920
ccatgaagcg ggtcaacttt cagttgccgg cggaggatca caccaagctg aagatgtacg 4980
cggtacgcca aggcaagacc attaccgagc tgctatctga atacatcgcg cagctaccag 5040
agtaaatgag caaatgaata aatgagtaga tgaattttag cggctaaagg aggcggcatg 5100
gaaaatcaag aacaaccagg caccgacgcc gtggaatgcc ccatgtgtgg aggaacgggc 5160
ggttggccag gcgtaagcgg ctgggttgtc tgccggccct gcaatggcac tggaaccccc 5220
aagcccgagg aatcggcgtg acggtcgcaa accatccggc ccggtacaaa tcggcgcggc 5280
gctgggtgat gacctggtgg agaagttgaa ggccgcgcag gccgcccagc ggcaacgcat 5340
cgaggcagaa gcacgccccg gtgaatcgtg gcaagcggcc gctgatcgaa tccgcaaaga 5400
atcccggcaa ccgccggcag ccggtgcgcc gtcgattagg aagccgccca agggcgacga 5460
gcaaccagat tttttcgttc cgatgctcta tgacgtgggc acccgcgata gtcgcagcat 5520
catggacgtg gccgttttcc gtctgtcgaa gcgtgaccga cgagctggcg aggtgatccg 5580
ctacgagctt ccagacgggc acgtagaggt ttccgcaggg ccggccggca tggccagtgt 5640
gtgggattac gacctggtac tgatggcggt ttcccatcta accgaatcca tgaaccgata 5700
ccgggaaggg aagggagaca agcccggccg cgtgttccgt ccacacgttg cggacgtact 5760
caagttctgc cggcgagccg atggcggaaa gcagaaagac gacctggtag aaacctgcat 5820
tcggttaaac accacgcacg ttgccatgca gcgtacgaag aaggccaaga acggccgcct 5880
ggtgacggta tccgagggtg aagccttgat tagccgctac aagatcgtaa agagcgaaac 5940
cgggcggccg gagtacatcg agatcgagct agctgattgg atgtaccgcg agatcacaga 6000
aggcaagaac ccggacgtgc tgacggttca ccccgattac tttttgatcg atcccggcat 6060
cggccgtttt ctctaccgcc tggcacgccg cgccgcaggc aaggcagaag ccagatggtt 6120
gttcaagacg atctacgaac gcagtggcag cgccggagag ttcaagaagt tctgtttcac 6180
cgtgcgcaag ctgatcgggt caaatgacct gccggagtac gatttgaagg aggaggcggg 6240
gcaggctggc ccgatcctag tcatgcgcta ccgcaacctg atcgagggcg aagcatccgc 6300
cggttcctaa tgtacggagc agatgctagg gcaaattgcc ctagcagggg aaaaaggtcg 6360
aaaaggtctc tttcctgtgg atagcacgta cattgggaac ccaaagccgt acattgggaa 6420
ccggaacccg tacattggga acccaaagcc gtacattggg aaccggtcac acatgtaagt 6480
gactgatata aaagagaaaa aaggcgattt ttccgcctaa aactctttaa aacttattaa 6540
aactcttaaa acccgcctgg cctgtgcata actgtctggc cagcgcacag ccgaagagct 6600
gcaaaaagcg cctacccttc ggtcgctgcg ctccctacgc cccgccgctt cgcgtcggcc 6660
tatcgcggcc gctggccgct caaaaatggc tggcctacgg ccaggcaatc taccagggcg 6720
cggacaagcc gcgccgtcgc cactcgaccg ccggcgccca catcaaggca ccctgcctcg 6780
cgcgtttcgg tgatgacggt gaaaacctct gacacatgca gctcccggag acggtcacag 6840
cttgtctgta agcggatgcc gggagcagac aagcccgtca gggcgcgtca gcgggtgttg 6900
gcgggtgtcg gggcgcagcc atgacccagt cacgtagcga tagcggagtg tatactggct 6960
taactatgcg gcatcagagc agattgtact gagagtgcac catatgcggt gtgaaatacc 7020
gcacagatgc gtaaggagaa aataccgcat caggcgctct tccgcttcct cgctcactga 7080
ctcgctgcgc tcggtcgttc ggctgcggcg agcggtatca gctcactcaa aggcggtaat 7140
acggttatcc acagaatcag gggataacgc aggaaagaac atgtgagcaa aaggccagca 7200
aaaggccagg aaccgtaaaa aggccgcgtt gctggcgttt ttccataggc tccgcccccc 7260
tgacgagcat cacaaaaatc gacgctcaag tcagaggtgg cgaaacccga caggactata 7320
aagataccag gcgtttcccc ctggaagctc cctcgtgcgc tctcctgttc cgaccctgcc 7380
gcttaccgga tacctgtccg cctttctccc ttcgggaagc gtggcgcttt ctcatagctc 7440
acgctgtagg tatctcagtt cggtgtaggt cgttcgctcc aagctgggct gtgtgcacga 7500
accccccgtt cagcccgacc gctgcgcctt atccggtaac tatcgtcttg agtccaaccc 7560
ggtaagacac gacttatcgc cactggcagc agccactggt aacaggatta gcagagcgag 7620
gtatgtaggc ggtgctacag agttcttgaa gtggtggcct aactacggct acactagaag 7680
gacagtattt ggtatctgcg ctctgctgaa gccagttacc ttcggaaaaa gagttggtag 7740
ctcttgatcc ggcaaacaaa ccaccgctgg tagcggtggt ttttttgttt gcaagcagca 7800
gattacgcgc agaaaaaaag gatctcaaga agatcctttg atcttttcta cggggtctga 7860
cgctcagtgg aacgaaaact cacgttaagg gattttggtc atgcattcta ggtactaaaa 7920
caattcatcc agtaaaatat aatattttat tttctcccaa tcaggcttga tccccagtaa 7980
gtcaaaaaat agctcgacat actgttcttc cccgatatcc tccctgatcg accggacgca 8040
gaaggcaatg tcataccact tgtccgccct gccgcttctc ccaagatcaa taaagccact 8100
tactttgcca tctttcacaa agatgttgct gtctcccagg tcgccgtggg aaaagacaag 8160
ttcctcttcg ggcttttccg tctttaaaaa atcatacagc tcgcgcggat ctttaaatgg 8220
agtgtcttct tcccagtttt cgcaatccac atcggccaga tcgttattca gtaagtaatc 8280
caattcggct aagcggctgt ctaagctatt cgtataggga caatccgata tgtcgatgga 8340
gtgaaagagc ctgatgcact ccgcatacag ctcgataatc ttttcagggc tttgttcatc 8400
ttcatactct tccgagcaaa ggacgccatc ggcctcactc atgagcagat tgctccagcc 8460
atcatgccgt tcaaagtgca ggacctttgg aacaggcagc tttccttcca gccatagcat 8520
catgtccttt tcccgttcca catcataggt ggtcccttta taccggctgt ccgtcatttt 8580
taaatatagg ttttcatttt ctcccaccag cttatatacc ttagcaggag acattccttc 8640
cgtatctttt acgcagcggt atttttcgat cagttttttc aattccggtg atattctcat 8700
tttagccatt tattatttcc ttcctctttt ctacagtatt taaagatacc ccaagaagct 8760
aattataaca agacgaactc caattcactg ttccttgcat tctaaaacct taaataccag 8820
aaaacagctt tttcaaagtt gttttcaaag ttggcgtata acatagtatc gacggagccg 8880
attttgaaac cgcggtgatc acaggcagca acgctctgtc atcgttacaa tcaacatgct 8940
accctccgcg agatcatccg tgtttcaaac ccggcagctt agttgccgtt cttccgaata 9000
gcatcggtaa catgagcaaa gtctgccgcc ttacaacggc tctcccgctg acgccgtccc 9060
ggactgatgg gctgcctgta tcgagtggtg attttgtgcc gagctgccgg tcggggagct 9120
gttggctggc tggtggcagg atatattgtg gtgtaaacaa attgacgctt agacaactta 9180
ataacacatt gcggacgttt ttaatgtact gaattaacgc cgaattaatt cgggggatct 9240
ggattttagt actggatttt ggttttagga attagaaatt ttattgatag aagtatttta 9300
caaatacaaa tacatactaa gggtttctta tatgctcaac acatgagcga aaccctatag 9360
gaaccctaat tcccttatct gggaactact cacacattat tatggagaaa ctcgagcttg 9420
tcgatcgaca gatccggtcg gcatctactc tatttctttg ccctcggacg agtgctgggg 9480
cgtcggtttc cactatcggc gagtacttct acacagccat cggtccagac ggccgcgctt 9540
ctgcgggcga tttgtgtacg cccgacagtc ccggctccgg atcggacgat tgcgtcgcat 9600
cgaccctgcg cccaagctgc atcatcgaaa ttgccgtcaa ccaagctctg atagagttgg 9660
tcaagaccaa tgcggagcat atacgcccgg agtcgtggcg atcctgcaag ctccggatgc 9720
ctccgctcga agtagcgcgt ctgctgctcc atacaagcca accacggcct ccagaagaag 9780
atgttggcga cctcgtattg ggaatccccg aacatcgcct cgctccagtc aatgaccgct 9840
gttatgcggc cattgtccgt caggacattg ttggagccga aatccgcgtg cacgaggtgc 9900
cggacttcgg ggcagtcctc ggcccaaagc atcagctcat cgagagcctg cgcgacggac 9960
gcactgacgg tgtcgtccat cacagtttgc cagtgataca catggggatc agcaatcgcg 10020
catatgaaat cacgccatgt agtgtattga ccgattcctt gcggtccgaa tgggccgaac 10080
ccgctcgtct ggctaagatc ggccgcagcg atcgcatcca tagcctccgc gaccggttgt 10140
agaacagcgg gcagttcggt ttcaggcagg tcttgcaacg tgacaccctg tgcacggcgg 10200
gagatgcaat aggtcaggct ctcgctaaac tccccaatgt caagcacttc cggaatcggg 10260
agcgcggccg atgcaaagtg ccgataaaca taacgatctt tgtagaaacc atcggcgcag 10320
ctatttaccc gcaggacata tccacgccct cctacatcga agctgaaagc acgagattct 10380
tcgccctccg agagctgcat caggtcggag acgctgtcga acttttcgat cagaaacttc 10440
tcgacagacg tcgcggtgag ttcaggcttt ttcatatctc attgcccccc cggatctgcg 10500
aaagctcgag agagatagat ttgtagagag agactggtga tttcagcgtg tcctctccaa 10560
atgaaatgaa cttccttata tagaggaagg tcttgcgaag gatagtggga ttgtgcgtca 10620
tcccttacgt cagtggagat atcacatcaa tccacttgct ttgaagacgt ggttggaacg 10680
tcttcttttt ccacgatgct cctcgtgggt gggggtccat ctttgggacc actgtcggca 10740
gaggcatctt gaacgatagc ctttccttta tcgcaatgat ggcatttgta ggtgccacct 10800
tccttttcta ctgtcctttt gatgaagtga cagatagctg ggcaatggaa tccgaggagg 10860
tttcccgata ttaccctttg ttgaaaagtc tcaatagccc tttggtcttc tgagactgta 10920
tctttgatat tcttggagta gacgagagtg tcgtgctcca ccatgttatc acatcaatcc 10980
acttgctttg aagacgtggt tggaacgtct tctttttcca cgatgctcct cgtgggtggg 11040
ggtccatctt tgggaccact gtcggcagag gcatcttgaa cgatagcctt tcctttatcg 11100
caatgatggc atttgtaggt gccaccttcc ttttctactg tccttttgat gaagtgacag 11160
atagctgggc aatggaatcc gaggaggttt cccgatatta ccctttgttg aaaagtctca 11220
atagcccttt ggtcttctga gactgtatct ttgatattct tggagtagac gagagtgtcg 11280
tgctccacca tgttggcaag ctgctctagc caatacgcaa accgcctctc cccgcgcgtt 11340
ggccgattca ttaatgcagc tggcacgaca ggtttcccga ctggaaagcg ggcagtgagc 11400
gcaacgcaat taatgtgagt tagctcactc attaggcacc ccaggcttta cactttatgc 11460
ttccggctcg tatgttgtgt ggaattgtga gcggataaca atttcacaca ggaaacagct 11520
atgaccatga ttacg 11535
<210>4
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>4
caccatttct ccgtctgtct gat 23
<210>5
<211>15
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>5
gccgcggcca tctca 15
<210>6
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>6
gacttccaag ttccaacaac tac 23
<210>7
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>7
cgttaaaaac aagaagaaga ag 22
<210>8
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>8
caaagttaat agtgatcagg cg 22
<210>9
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>9
cgaatttgcc tcgacttttg aag 23
<210>10
<211>19
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>10
tcggaagttg gctcggttt 19
<210>11
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>11
acttttgagc acgcgagaga a 21
<210>12
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>12
caccatttct ccgtctgtct gat 23
<210>13
<211>15
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>13
gccgcggcca tctca 15
<210>14
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>14
atgggaagtt tgggggcaat tct 23
<210>15
<211>28
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>15
gttctcactg tttgttcagt agtaggtt 28

Claims (6)

1. Application of transcription factor PgWRKY4X in regulating ginsenoside compound content in Ginseng radix; the amino acid sequence of the ginseng PgWRKY4X transcription factor is shown in SEQ ID No. 1.
2. The use of claim 1, wherein the ginsenoside compound is ginsenoside Rb1Or Rg1Or Re.
3. The application of the coding gene of the ginseng PgWRKY4X transcription factor in regulating and controlling the content of ginsenoside compounds in the ginseng is disclosed, wherein the nucleotide sequence of the coding gene is shown as SEQ ID No. 2.
4. The use of claim 3, wherein the ginsenoside compound is ginsenoside Rb1Or Rg1Or Re。
5. An application of an overexpression recombinant vector containing a ginseng PgWRKY4X transcription factor coding gene in regulating and controlling the content of ginsenoside compounds in ginseng is disclosed, wherein a nucleotide sequence of the overexpression recombinant vector is shown as SEQ ID No. 3.
6. The use of claim 5, wherein the ginsenoside compound is ginsenoside Rb1Or Rg1Or Re.
CN202010129213.XA 2020-02-28 2020-02-28 Application of ginseng PgWRKY4X transcription factor in regulating and controlling ginsenoside compound content in ginseng Active CN111217896B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010129213.XA CN111217896B (en) 2020-02-28 2020-02-28 Application of ginseng PgWRKY4X transcription factor in regulating and controlling ginsenoside compound content in ginseng

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010129213.XA CN111217896B (en) 2020-02-28 2020-02-28 Application of ginseng PgWRKY4X transcription factor in regulating and controlling ginsenoside compound content in ginseng

Publications (2)

Publication Number Publication Date
CN111217896A true CN111217896A (en) 2020-06-02
CN111217896B CN111217896B (en) 2022-04-29

Family

ID=70807665

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010129213.XA Active CN111217896B (en) 2020-02-28 2020-02-28 Application of ginseng PgWRKY4X transcription factor in regulating and controlling ginsenoside compound content in ginseng

Country Status (1)

Country Link
CN (1) CN111217896B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111534523A (en) * 2020-06-28 2020-08-14 吉林农业大学 Ginseng radixPgHDZ01Gene and application thereof in improving ginsenoside content
CN113493795A (en) * 2021-08-03 2021-10-12 昆明理工大学 Preparation method of ginsenoside Rh2
CN114891803A (en) * 2022-05-30 2022-08-12 湖南工程学院 Ginseng PgWRKY40 gene induced by methyl jasmonate and application thereof
CN115260299A (en) * 2022-05-12 2022-11-01 成都大学 Ginseng PgWRKY2 transcription factor and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103103194A (en) * 2013-02-05 2013-05-15 中南大学 Gene promoter of ginseng PgPDR3 responded by methyl jasmonate and application thereof
CN105087601A (en) * 2015-09-07 2015-11-25 昆明理工大学 Application of panax japonicus transcription factor gene PjWRKY1
CN109852618A (en) * 2018-12-17 2019-06-07 广东省农业科学院蔬菜研究所 A kind of section melon WRKY class transcription factor gene CqWRKY1 and its application
CN110438099A (en) * 2018-05-04 2019-11-12 中国科学院天津工业生物技术研究所 The application of glycosyl transferase and its associated materials in the engineering bacteria that building produces ginsenoside Rb1 and Rg1
CN110747202A (en) * 2019-11-13 2020-02-04 昆明理工大学 Lilium regale WRKY transcription factor gene LrWRKY11 and application thereof
CN110791490A (en) * 2019-11-15 2020-02-14 东北师范大学 Recombinant β -glucosidase CB-3B and application thereof in production of ginsenoside Rg3

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103103194A (en) * 2013-02-05 2013-05-15 中南大学 Gene promoter of ginseng PgPDR3 responded by methyl jasmonate and application thereof
CN105087601A (en) * 2015-09-07 2015-11-25 昆明理工大学 Application of panax japonicus transcription factor gene PjWRKY1
CN110438099A (en) * 2018-05-04 2019-11-12 中国科学院天津工业生物技术研究所 The application of glycosyl transferase and its associated materials in the engineering bacteria that building produces ginsenoside Rb1 and Rg1
CN109852618A (en) * 2018-12-17 2019-06-07 广东省农业科学院蔬菜研究所 A kind of section melon WRKY class transcription factor gene CqWRKY1 and its application
CN110747202A (en) * 2019-11-13 2020-02-04 昆明理工大学 Lilium regale WRKY transcription factor gene LrWRKY11 and application thereof
CN110791490A (en) * 2019-11-15 2020-02-14 东北师范大学 Recombinant β -glucosidase CB-3B and application thereof in production of ginsenoside Rg3

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HAO XIU等: "Molecular Cloning and Expression Analysis of Eight PgWRKY Genes in Panax ginseng Responsive to Salt and Hormones", 《INT. J. MOL. SCI.》 *
SHIHUI WANG等: "Effect of temperature on morphology, ginsenosides biosynthesis, functional genes, and transcriptional factors expression in Panax ginseng adventitious roots", 《J FOOD BIOCHEM.》 *
YAO,L. 等: "Panax ginseng WRKY transcription factor 4X mRNA, partial cds", 《GENBANK DATABASE》 *
YAO,L.等: "WRKY transcription factor 4X, partial [Panax ginseng]", 《GENBANK DATABASE》 *
王梓等: "人参中苯甲酸胁迫响应基因WRKY7的克隆与表达分析", 《中国中药杂志》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111534523A (en) * 2020-06-28 2020-08-14 吉林农业大学 Ginseng radixPgHDZ01Gene and application thereof in improving ginsenoside content
CN111534523B (en) * 2020-06-28 2023-01-31 吉林农业大学 Ginseng PgHDZ01 gene and application thereof in improving ginsenoside content
CN113493795A (en) * 2021-08-03 2021-10-12 昆明理工大学 Preparation method of ginsenoside Rh2
CN113493795B (en) * 2021-08-03 2022-10-28 昆明理工大学 Preparation method of ginsenoside Rh2
CN115260299A (en) * 2022-05-12 2022-11-01 成都大学 Ginseng PgWRKY2 transcription factor and application thereof
CN114891803A (en) * 2022-05-30 2022-08-12 湖南工程学院 Ginseng PgWRKY40 gene induced by methyl jasmonate and application thereof
CN114891803B (en) * 2022-05-30 2023-06-23 湖南工程学院 Ginseng PgWRKY40 gene induced by methyl jasmonate and application thereof

Also Published As

Publication number Publication date
CN111217896B (en) 2022-04-29

Similar Documents

Publication Publication Date Title
CN111217896B (en) Application of ginseng PgWRKY4X transcription factor in regulating and controlling ginsenoside compound content in ginseng
KR101234981B1 (en) Nucleic Acid Constructs
CA2772928C (en) Methods of reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity
AU2017376780A1 (en) Compositions and methods for modulating growth of a genetically modified gut bacterial cell
CN114230677B (en) Recombinant protein containing Cap of hog cholera E2 and circovirus, preparation method and application thereof
CN111527211B (en) Microorganism producing mycosporine-like amino acid and method for producing mycosporine-like amino acid using the same
CN115094068B (en) Application of OsbHLH189 gene in improving rice grain type
CN111004755A (en) Citrobacter T26 for specifically degrading hyaluronic acid, hyaluronidase HylC produced by Citrobacter T26 and application of hyaluronidase HylC
CN112831519B (en) Method for preparing santalol by utilizing sweet wormwood herbs
CN113943748B (en) Recombination system in pseudomonas syringae and application
CN107227312B (en) Method for increasing content of salvianolic acid B in hairy roots of salvia miltiorrhiza and laccase gene
CN114438115A (en) CRISPR/Cas9 gene editing vector, construction method and application thereof
CN112501177B (en) Method for promoting development of lateral root of salvia miltiorrhiza and improving content of tanshinone in salvia miltiorrhiza root, salvia miltiorrhiza gene sequence and overexpression vector
CN108728390B (en) Genetically engineered bacterium for producing A82846B as well as preparation method and application thereof
CN113880957A (en) Streptolysin O fusion protein
CN111965367A (en) Application of HIP-55 as GPCR biased drug target
CN114540410A (en) Application of transcription factor CsDUF1 for regulating and controlling synthesis of caffeine of tea tree in regulating and controlling synthesis of caffeine of tea tree
CN112251413B (en) Preparation method, cell and application of cell for transmembrane expression of novel coronavirus antigen
CN112280798B (en) Spinach green RNA visualization-based method and application thereof
CN114621974B (en) Vector of plant single-gene or multi-gene CRISPR (clustered regularly interspaced short palindromic surface plasmon) activation technology, and construction method and application thereof
CN116804179A (en) Engineering bacterium for producing terramycin and construction method and application thereof
CN117050994A (en) Optimized viral vector subgenomic promoters and uses thereof
CN114573667B (en) Mutant strain DNA vaccine of SARS-CoV-2 virus B.1.1.529 and application thereof
CN110846334B (en) Upland cotton transformation event ICR24-378 and application thereof in cotton breeding
CN108220312A (en) For the carrier for analyzing promoter activity and the Assay of promoter activity method counted based on RNA

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP02 Change in the address of a patent holder

Address after: 300452 Binhai Industrial Research Institute Campus of Tianjin University, No. 48 Jialingjiang Road, Binhai New Area, Tianjin

Patentee after: Tianjin University

Address before: 300072 Tianjin City, Nankai District Wei Jin Road No. 92

Patentee before: Tianjin University

CP02 Change in the address of a patent holder